SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ADVENTRX Pharmaceuticals Inc (Anx)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: mo_lucre12/15/2006 9:47:25 PM
Read Replies (1) of 418
 
Keith, I just wanted to make sure you saw that I posted my best guess on ANX's partner. If you think about what Levine said at the conference and then tie all the players together it adds up. BMY/IMCLONE/ICAHN/DENNER. Most people would never think that BMY would partner with ANX until you consider the players. BMY would not want to buy-out ANX, but they offer everything Levine was referring to. Licensing deal with a large Pharma., worldwide sales, additional trials to expand Co-factors indications. They could make the deal before Phase IIb results are even released.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext